Hesperos Inc.
Steven Cheney currently serves as a Student Doctor at Oklahoma State University since August 2022 and has been a Research Assistant at Hesperos Inc. since June 2019, where responsibilities include conducting data analysis, interpreting project results, and integrating advanced techniques in experimental design and device fabrication. Steven Cheney is pursuing a degree at the Oklahoma State University Center for Health Sciences, expected to complete in June 2026, after earning a Bachelor of Biomedical Sciences from the University of Central Florida in 2022 with a 4.0 GPA.
Hesperos Inc.
Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organsystems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.